-+ 0.00%
-+ 0.00%
-+ 0.00%

China XLX Fertiliser (SEHK:1866) Shares Climbed, What Is Behind The Attention?

Simply Wall St·08/30/2026 13:23:56
语音播报

China XLX Fertiliser earnings jump draws investor attention

China XLX Fertiliser (SEHK:1866) has come into focus after reporting half year 2026 sales of CNY 15,739.67 million and net income of CNY 920.77 million, both above the prior year period.

The company also reported basic and diluted earnings per share from continuing operations of CNY 0.739, compared with CNY 0.4919 and CNY 0.4865 respectively a year earlier. This gives investors fresh data to reassess the stock.

At a share price of HK$10.57, China XLX Fertiliser has a 1 month share price return of 16.92% and a year to date share price return of 15.39%. The 1 year total shareholder return of 49.54% suggests momentum has been building over a longer period.

Compare China XLX Fertiliser's earnings momentum with a curated group of stocks that pair strong fundamentals with potential upside in our 267 high quality undervalued stocks.

China XLX Fertiliser now combines broad product reach with stronger reported earnings and a sharp share price move. The next step is to see whether that business strength is already fully reflected in the valuation.

Price-to-earnings of 14.1x for China XLX Fertiliser: Is it justified?

China XLX Fertiliser last closed at HK$10.57 and is on a P/E of 14.1x, which screens as expensive compared with several benchmarks.

The P/E ratio compares the current share price with earnings per share. For a business like China XLX Fertiliser, which operates across fertilizers, chemicals and energy related products, this multiple is a quick way for investors to see how much the market is paying for each unit of reported profit.

At 14.1x earnings, the stock trades above the Hong Kong Chemicals industry average P/E of 9.9x and also above an estimated fair P/E of 12.7x. That suggests investors are currently paying a premium relative to both sector peers and a level the market could potentially gravitate toward if expectations or sentiment change.

To see how this relationship between price and earnings stacks up over time, and how it links to fair value, explore the Explore the SWS fair ratio for China XLX Fertiliser.

Result: Price-to-earnings of 14.1x (OVERVALUED)

However, investors in China XLX Fertiliser still face risks from its exposure to cyclical fertilizer and chemicals demand, as well as the breadth of its non core activities.

Find out about the key risks to this China XLX Fertiliser narrative.

Another view on China XLX Fertiliser's valuation

While the 14.1x P/E suggests China XLX Fertiliser is expensive relative to peers and a fair ratio of 12.7x, the SWS DCF model points the other way. At HK$10.57, the stock is trading below an estimated future cash flow value of HK$16.42, which frames it as undervalued on that measure. Which signal should carry more weight for you?

Look into how the SWS DCF model arrives at its fair value.

1866 Discounted Cash Flow as at Aug 2026
1866 Discounted Cash Flow as at Aug 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out China XLX Fertiliser for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 267 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mix of stronger reported figures and valuation questions around China XLX Fertiliser, it makes sense to check the underlying detail yourself soon and decide where you stand. To weigh up both the concerns and the positives in one place, review the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond China XLX Fertiliser?

If China XLX Fertiliser has your attention, do not stop there. A few minutes with a focused stock screener can surface other opportunities that match your style.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.